Clinical Trial Update: Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating neo-adjuvant transarterial chemoinfusion for hepatocellular carcinoma patients beyond Milan/UCSF criteria undergoing liver tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Transplantation

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Hepatocellular Carcinoma, Liver Transplantation | Phase 3 | Status: RECRUITING